Intravenous high-dose vitamin C is being investigated as a potential life-saving treatment for sepsis, a deadly immune response to infection. A recent clinical trial published in JAMA found that patients receiving vitamin C infusions alongside standard care had a 30% lower mortality rate than those receiving standard treatment alone. The study involved 200 sepsis patients, with those in the treatment group receiving 1.5 grams of vitamin C every six hours for four days.
Dr. Alpha Fowler, a critical care specialist involved in the research, explained that vitamin C’s antioxidant properties help mitigate the excessive inflammation and oxidative stress seen in sepsis. “Vitamin C supports endothelial function and reduces organ damage, which is crucial for survival,” he said. While the results are promising, larger trials are necessary before this treatment becomes standard practice.
Critics argue that the study’s sample size was small and that previous trials have yielded mixed results. However, given the lack of effective treatments for sepsis—which kills nearly 11 million people annually—this research opens a new avenue for exploration. Some hospitals have already begun incorporating vitamin C protocols for sepsis patients, though official guidelines have yet to be updated.
You Might Be Interested In:
- AI-Powered Wearable Detects Early Parkinson’s Disease Through Breathing Patterns
- Groundbreaking Study Reveals Gut Microbiome’s Role in Preventing Chronic Inflammation
- Rediscovered Ancient Cooking Technique Unlocks Hidden Nutrition in Common Vegetables
